오믹스 랩 서비스 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 서비스별, 서비스 빈도별, 사업별, 최종사용별, 지역별, 경쟁별(2020-2030년)

The Global Omics Lab Services Market was valued at USD 72.51 billion in 2024 and is projected to reach USD 124.61 billion by 2030, growing at a CAGR of 9.44% during the forecast period. This rapidly advancing market spans genomics, proteomics, metabolomics, transcriptomics, and epigenetics, and plays a crucial role in understanding complex biological systems. These services support disease diagnosis, biomarker discovery, and precision treatment development. The increasing demand for personalized medicine, advancements in high-throughput sequencing, and rising use of omics in sectors such as drug discovery, agriculture, and environmental sciences are propelling market growth. As technologies evolve, omics lab services continue to expand their applications and influence in modern science and healthcare.

Key Market Drivers

Growing Integration Of Genomics Data Into Clinical Workflows

The integration of genomics data into clinical workflows is transforming healthcare and driving significant growth in the Omics Lab Services Market. Genomic insights are reshaping disease diagnosis, risk assessment, and personalized treatment approaches. With increasing accessibility and affordability of genomic data, healthcare providers can now identify patient-specific genetic mutations and susceptibilities, allowing for more targeted and effective interventions. Technologies like high-throughput sequencing and advanced bioinformatics are streamlining the analysis and interpretation of complex datasets, making genomics integration into everyday clinical practices both feasible and beneficial. Omics service providers play a vital role in enabling this transition, delivering the analytical capabilities and expertise required to support precision medicine initiatives.

Key Market Challenges

Lack Of Skilled Professionals

A major challenge facing the Omics Lab Services Market is the shortage of skilled professionals capable of managing and interpreting complex omics data. The sector requires expertise across molecular biology, bioinformatics, and data analytics-fields where highly trained personnel are in short supply. Particularly in bioinformatics, the volume and complexity of data generated by omics platforms necessitate specialized skills in data mining, coding, and statistical analysis. This talent gap leads to data processing delays and limits the scalability of omics services. Furthermore, effective collaboration across interdisciplinary teams is essential, and the lack of professionals capable of bridging these domains impedes broader adoption and integration of omics into healthcare and research.

Key Market Trends

Personalized Medicine

Personalized medicine is a transformative trend reshaping the Omics Lab Services Market by customizing healthcare to individual genetic and molecular profiles. Omics technologies, particularly genomics and proteomics, enable healthcare providers to uncover disease markers and identify therapeutic targets unique to each patient. This is particularly impactful in oncology, where tumor-specific genetic analysis informs the selection of targeted therapies, improving outcomes and reducing adverse effects. Beyond cancer, personalized medicine is expanding into areas such as cardiology, neurology, and rare genetic disorders. The rise of direct-to-consumer genetic testing is further fueling public interest, empowering individuals to take a proactive approach to their health based on personal genetic insights.

Key Market Players

• Agilent Technologies, Inc.
• Q2 Solutions LLC
• Flomics Biotech
• QIAGEN N.V.
• Thermo Fisher Scientific Inc.
• Illumina, Inc
• Quest Diagnostics Incorporated
• Phenoswitch Bioscience
• Spectrus Corporation
• BEIJING GENOMICS INSTITUTE

Report Scope:

In this report, the Global Omics Lab Services Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Omics Lab Services Market, By Service:

• Genomics
• Proteomics
• Transcriptomics
• Metabolomics
• Epigenetics

Omics Lab Services Market, By Frequency Of Service:

• One-Off
• Repeat
• Continuous

Omics Lab Services Market, By Business:

• Hospitals
• Research Institutes
• Diagnostic Labs

Omics Lab Services Market, By End Use:

• Cancer
• Pharmaco
• Reproductive
• Other Genetic Disease

Omics Lab Services Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Omics Lab Services Market.

Available Customizations:

Global Omics Lab Services market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Omics Lab Services Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Service (Genomics, Proteomics, Transcriptomics, Metabolomics, Epigenetics)
  • 5.2.2. By Frequency Of Service (One-Off, Repeat, Continuous)
  • 5.2.3. By Business (Hospitals, Research Institutes, Diagnostic Labs)
  • 5.2.4. By End Use (Cancer, Pharmaco, Reproductive, Other Genetic Disease) By Region
  • 5.2.5. By Company (2024)
  • 5.2.6. By Region
• 5.3. Market Map

6. North America Omics Lab Services Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Service
  • 6.2.2. By Frequency of Service
  • 6.2.3. By Business
  • 6.2.4. By End Use
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Omics Lab Services Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Service
      • 6.3.1.2.2. By Frequency of Service
      • 6.3.1.2.3. By Business
      • 6.3.1.2.4. By End Use
  • 6.3.2. Canada Omics Lab Services Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Service
      • 6.3.2.2.2. By Frequency of Service
      • 6.3.2.2.3. By Business
      • 6.3.2.2.4. By End Use
  • 6.3.3. Mexico Omics Lab Services Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Service
      • 6.3.3.2.2. By Frequency of Service
      • 6.3.3.2.3. By Business
      • 6.3.3.2.4. By End Use

7. Europe Omics Lab Services Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Service
  • 7.2.2. By Frequency of Service
  • 7.2.3. By Business
  • 7.2.4. By End Use
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Omics Lab Services Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Service
      • 7.3.1.2.2. By Frequency of Service
      • 7.3.1.2.3. By Business
      • 7.3.1.2.4. By End Use
  • 7.3.2. United Kingdom Omics Lab Services Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Service
      • 7.3.2.2.2. By Frequency of Service
      • 7.3.2.2.3. By Business
      • 7.3.2.2.4. By End Use
  • 7.3.3. Italy Omics Lab Services Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Service
      • 7.3.3.2.2. By Frequency of Service
      • 7.3.3.2.3. By Business
      • 7.3.3.2.4. By End Use
  • 7.3.4. France Omics Lab Services Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Service
      • 7.3.4.2.2. By Frequency of Service
      • 7.3.4.2.3. By Business
      • 7.3.4.2.4. By End Use
  • 7.3.5. Spain Omics Lab Services Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Service
      • 7.3.5.2.2. By Frequency of Service
      • 7.3.5.2.3. By Business
      • 7.3.5.2.4. By End Use

8. Asia-Pacific Omics Lab Services Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Service
  • 8.2.2. By Frequency of Service
  • 8.2.3. By Business
  • 8.2.4. By End Use
  • 8.2.5. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Omics Lab Services Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Service
      • 8.3.1.2.2. By Frequency of Service
      • 8.3.1.2.3. By Business
      • 8.3.1.2.4. By End Use
  • 8.3.2. India Omics Lab Services Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Service
      • 8.3.2.2.2. By Frequency of Service
      • 8.3.2.2.3. By Business
      • 8.3.2.2.4. By End Use
  • 8.3.3. Japan Omics Lab Services Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Service
      • 8.3.3.2.2. By Frequency of Service
      • 8.3.3.2.3. By Business
      • 8.3.3.2.4. By End Use
  • 8.3.4. South Omics Lab Services Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Service
      • 8.3.4.2.2. By Frequency of Service
      • 8.3.4.2.3. By Business
      • 8.3.4.2.4. By End Use
  • 8.3.5. Australia Omics Lab Services Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Service
      • 8.3.5.2.2. By Frequency of Service
      • 8.3.5.2.3. By Business
      • 8.3.5.2.4. By End Use

9. South America Omics Lab Services Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Service
  • 9.2.2. By Frequency of Service
  • 9.2.3. By Business
  • 9.2.4. By End Use
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Omics Lab Services Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Service
      • 9.3.1.2.2. By Frequency of Service
      • 9.3.1.2.3. By Business
      • 9.3.1.2.4. By End Use
  • 9.3.2. Argentina Omics Lab Services Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Service
      • 9.3.2.2.2. By Frequency of Service
      • 9.3.2.2.3. By Business
      • 9.3.2.2.4. By End Use
  • 9.3.3. Colombia Omics Lab Services Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Service
      • 9.3.3.2.2. By Frequency of Service
      • 9.3.3.2.3. By Business
      • 9.3.3.2.4. By End Use

10. Middle East and Africa Omics Lab Services Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Service
  • 10.2.2. By Frequency of Service
  • 10.2.3. By Business
  • 10.2.4. By End Use
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Omics Lab Services Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Service
      • 10.3.1.2.2. By Frequency of Service
      • 10.3.1.2.3. By Business
      • 10.3.1.2.4. By End Use
  • 10.3.2. Saudi Arabia Omics Lab Services Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Service
      • 10.3.2.2.2. By Frequency of Service
      • 10.3.2.2.3. By Business
      • 10.3.2.2.4. By End Use
  • 10.3.3. UAE Omics Lab Services Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Service
      • 10.3.3.2.2. By Frequency of Service
      • 10.3.3.2.3. By Business
      • 10.3.3.2.4. By End Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Porters Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products/Services

14. Competitive Landscape

• 14.1. Agilent Technologies, Inc.
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. Q2 Solutions LLC
• 14.3. Flomics Biotech
• 14.4. QIAGEN N.V.
• 14.5. Thermo Fisher Scientific Inc.
• 14.6. Illumina, Inc
• 14.7. Quest Diagnostics Incorporated
• 14.8. Phenoswitch Bioscience
• 14.9. Spectrus Corporation
• 14.10. BEIJING GENOMICS INSTITUTE.

15. Strategic Recommendations

16. About Us & Disclaimer